Infection

 
Shingrix: Who Needs It and Who Doesn't?
May 12, 2022

A 55-year-old healthy man has a rash on his back that is diagnosed as shingles. He has never received any shingles vaccine–is he eligible now? Plus 3 more patient scenarios.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
May 11, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
May 10, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
May 09, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
May 06, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
May 04, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
May 03, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
May 02, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Remdesivir Wins FDA Approval for Treatment of COVID-19 in Youngest Patients
April 29, 2022

The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.

Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
April 28, 2022

The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.